DTL
EPZM

Dynamic Technology Lab’s Epizyme, Inc EPZM Stock Holding History

Dynamic Technology Lab’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-13,766
Closed -$120K – 1692
2021
Q1 		$120K Buy
+13,766
New +$142K 0.01% 1020
2020
Q4 		– Sell
-22,251
Closed -$265K – 1464
2020
Q3 		$265K Buy
+22,251
New +$298K 0.04% 711
2019
Q2 		– Sell
-17,201
Closed -$213K – 1392
2019
Q1 		$213K Buy
+17,201
New +$192K 0.03% 811
2018
Q3 		– Sell
-25,453
Closed -$345K – 1449
2018
Q2 		$345K Buy
+25,453
New +$396K 0.05% 626
2017
Q4 		– Sell
-24,104
Closed -$459K – 1440
2017
Q3 		$459K Buy
+24,104
New +$368K 0.07% 482
2016
Q3 		– Sell
-10,208
Closed -$104K – 1224
2016
Q2 		$104K Buy
+10,208
New +$114K 0.03% 797
2015
Q1 		– Sell
-10,530
Closed -$199K – 934
2014
Q4 		$199K Buy
+10,530
New +$246K 0.1% 493

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Dynamic Technology Lab's EPZM Position: Q2 2021 in Review

Dynamic Technology Lab sold out of Epizyme, Inc (EPZM) in Q2 2021, closing a stake of 13,766 shares — an estimated $120K sold.

Dynamic Technology Lab first reported a position in EPZM in Q4 2014 and held it in 7 quarters. The position peaked at $459K in Q3 2017. 127 funds tracked by Wall St. Rank hold EPZM as of Q2 2021.

  • Dynamic Technology Lab reported no remaining Epizyme, Inc position as of Q2 2021 after selling out during the quarter.
  • Dynamic Technology Lab sold 13,766 Epizyme, Inc shares in Q2 2021, an estimated $120K.
  • Dynamic Technology Lab first reported a position in Epizyme, Inc in Q4 2014 and held it in 7 quarters.
  • Dynamic Technology Lab's Epizyme, Inc position peaked at $459K in Q3 2017.
  • 127 funds tracked by Wall St. Rank held Epizyme, Inc as of Q2 2021.

Based on Dynamic Technology Lab's 13F filing for Q2 2021, filed 13 Aug 2021.